Proton pump inhibitors to control phosphorus levels in hemodialysis patients
Researchers and healthcare providers can advance the field of phosphorus control, ultimately improving patient outcomes and enhancing the overall quality of care for ESKD patients.
Saved in:
| Main Author: | Amineh Hojati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Babol University of Medical Sciences
2025-10-01
|
| Series: | Caspian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | http://caspjim.com/article-1-4165-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01) -
Change in Symptoms and Mucosal Findings after Proton Pump Inhibitor in Patients with Laryngopharyngeal Reflux
by: Min Woo Park, et al.
Published: (2025-01-01) -
Is there an overprescription of proton pump inhibitors in oncohematologic patients undergoing ambulatory oncospecific treatment?
by: Meritxell Pujal Herranz
Published: (2016-09-01) -
Proton pump inhibitors - possible side effects of long-term therapy: a review
by: Jan Kowalewski, et al.
Published: (2024-12-01) -
Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study
by: Niveen Khoury, et al.
Published: (2024-12-01)